Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,978 Psoriasis
clinical trials

Psoriasis Vulgaris Clinical Trial
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Psoriasis Vulgaris Clinical Trial
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridian Clinical Research, LLC
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Newton Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Synexus Clinical Research US, Inc.
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Dermatology Trial Associates
mi
from
Bryant, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
Status: Enrolling, Phase I
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Rogers, AR
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Arcutis Clinical Site 20
mi
from
Fridley, MN
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Arcutis Clinical Site 12
mi
from
Miami, FL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Arcutis Clinical Site 23
mi
from
San Antonio, TX
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Arcutis Clinical Site 28
mi
from
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
First OC Dermatology
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Integrated Research Group Inc
mi
from
Upland, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology Specialists of Spokane
mi
from
Spokane, WA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
South Coast Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
DS Research
mi
from
New Albany, IN
Click here to add this to my saved trials
Psoriasis Clinical Trial
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Status: Enrolling, Phase III
Updated: 12/31/1969
Derm Associates, P.C.
mi
from
Rockville, MD
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Allergy & Asthma Associates of Southern California dba Southern California Research
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Psoriasis Clinical Trial
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ciocca Dermatology
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Monitoring Of Scratch Via Accelerometry In Children
Status: Enrolling, Phase
Updated: 12/31/1969
Evans Biomedical Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Clarkston, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Dundee, IL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Nashua Dermatology
mi
from
Nashua, NH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Northwest Georgia Dermatology
mi
from
Rome, GA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Affiliated Dermatology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Andover, MA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 48
mi
from
Orlando, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 2/28/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 2/28/2017
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Clovis, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Fremont, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Newnan, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Plainfield, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Verona, NJ
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Shores Rheumatology, PC /ID# 162697
mi
from
Saint Clair Shores, MI
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
Status: Enrolling, Phase IV
Updated: 12/31/1969
PMG Research of Wilmington LLC /ID# 152089
mi
from
Wilmington, NC
Click here to add this to my saved trials
Psoriasis Clinical Trial
This Study is Being Conducted to Evaluate the Safety, Tolerability, and Efficacy of KD025 Administered Orally for 16 Weeks to Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy.
Status: Enrolling, Phase II
Updated: 3/6/2017
University of California, Irvine - Dermatology Clinical Research Center
mi
from
Irvine, CA
Click here to add this to my saved trials
Psoriasis Vulgaris Clinical Trial
Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).
Status: Enrolling, Phase IV
Updated: 12/31/1969
VA NY Harbor Healthcare System
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
AARDS Research, Inc. /ID# 161409
mi
from
Aventura, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
SW Rheumatology Res. LLC /ID# 160014
mi
from
Mesquite, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
DJL Clinical Research, PLLC /ID# 161390
mi
from
Charlotte, NC
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
MetroHealth Medical Center /ID# 159888
mi
from
Cleveland, OH
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Adriana Pop-Moody MD Clinic PA /ID# 159984
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
International Medical Research /ID# 160040
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
C.V. Mehta MD, Medical Corporation /ID# 161216
mi
from
Hemet, CA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
OrthoIllinois, Ltd /ID# 164546
mi
from
Rockford, IL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinvest Research LLC /ID# 161227
mi
from
Springfield, MO
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
DM Clinical Research /ID# 161735
mi
from
Tomball, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Rothhaar Studien GmbH
mi
from
Berlin,
Click here to add this to my saved trials
Psoriasis Vulgaris Clinical Trial
Efficacy and Safety of TC Cream In Treating Patients With Psoriasis Vulgaris
Status: Enrolling, Phase II
Updated: 4/3/2018
Department of Dermatology, State University of New York, Downstate Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Psoriasis Clinical Trial
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Overland Park, KS
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
Status: Enrolling
Updated: 12/31/1969
Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Wright State Univ School of Medicine
mi
from
Fairborn, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Riverchase Dermatology and Cosmetic Surgery
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California Davis-Dermatology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology Center of Canyon County
mi
from
Nampa, ID
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Arlington Dermatology
mi
from
Rolling Meadows, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 516
mi
from
Bexley, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 18
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 210
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 519
mi
from
Orange Park, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 361
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 343
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 226
mi
from
Webster, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Total Skin and Dermatology Center, PC.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Wright State Physicians
mi
from
Fairborn, OH
Click here to add this to my saved trials
1 … 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20